Abstract
The glycolytic enzyme triose phosphate isomerase from Schistosoma mansoni is a potential target for drugs and vaccines. Molecular modelling of the enzyme predicted that a Ser-Ala-Asp motif which is believed to be a helminth-specific epitope is exposed. The enzyme is dimeric (as judged by gel filtration and cross-linking), resistant to proteolysis and highly stable to thermal denaturation (melting temperature of 82.0 C). The steady-state kinetic parameters are high (Km for dihydroxyacetone phosphate is 0.51 mM; Km for glyceraldehyde 3-phosphate is 1.1 mM; kcat for dihydroxyacetone phosphate is 7800 s-1 and kcat for glyceraldehyde 3-phosphate is 6.9 s-1).
Original language | English |
---|---|
Pages (from-to) | 3422-3427 |
Number of pages | 6 |
Journal | Febs Letters |
Volume | 587 |
Issue number | 21 |
DOIs | |
Publication status | Published - 1 Nov 2013 |
Keywords
- Bilharzia
- Blood fluke
- Glycolytic enzyme
- Schistosomiasis
- Vaccine target